uniQure N.V. Overview
Company Headquarters: Amsterdam, Netherlands
Founded: 1998
Workforce: 200+
Company Working:
uniQure N.V. is engaged in development, manufacturing, and marketing of gene therapy products in the Europe and Americas. The company offers innovative technology, manufacturing platforms, and finished products for the treatment of rare disorders such as hemophilia B, Huntington’s disease, hemophilia A, Fabry disease, and central nervous system disorders. The company offers preclinical services, provide support to the development of drugs, manufacturing and marketing of gene therapy products related to the liver/metabolic, central nervous system and other chronic disorders.
Strategy
UniQure N.V. is known for its end to end services to the customers. The company spends large amount of its revenue on research and development activities and emphasizes on developing innovative technologies and products for the treatment of rare disorders. The company has strong presence in the Europe and Americas. The company has strong research and development department which is responsible for development of robust product pipeline. Moreover, the company aims to become industry-leading, fully integrated and global company with the help its innovative gene therapy products.
